Chief Executive Officer
Nitin has 20+ years of experience in drug development and has actively contributed to various drug delivery products from new chemical entities to drug delivery applications. He has held senior positions at Elan, Alkermes, ALZA (J&J), and also served as the Co-Founder of Incline Therapeutics (acquired by The Medicines Company).
Chief Commercial Officer
Srini is classically trained marketing executive with 20+ years’ experience building iconic brands such as Campbell Soup, Advil analgesics, & Vaseline skin care at blue-chip marketing organizations (P&G, Unilever, Campbell Soup, Pfizer). Most recently Srini was at Pfizer where he took Advil to global share leadership, overseeing an integrated commercial and R&D organization. Srini is an alumnus of Columbia Business School.
Chief Strategy Officer
Carmine is an industry veteran with 30+ years experience in pharma and med tech operations. He has held senior positions at Knoll/BASF Pharma, Abbott Laboratories, and was the VP of Corporate Development at BoneCare Int’l., sold to Genzyme (now Sanofi) for $660M. As a Co-Founder and former CEO of Zurex Pharma, Carmine has experience raising millions in equity and debt financings, and successfully executed several strategic transactions.
Director, Product Development
Marina has 14+ years of experience in drug development, commercial manufacturing, and expanding product portfolio. She has a wide experience in drug product submission with a proven record of FDA approvals. She joined the CAGE Bio team in 2018. Prior to joining CAGE, she held senior-level scientist positions at Perrigo and Allergan.
Senior Research Scientist, Product Development
Abhirup joined the CAGE Bio team in 2020 after completing his postdoctoral training from Harvard University, which was primarily focused on understanding ionic liquid (IL)-based frameworks for delivering nucleic acids transdermally. He received his Ph.D. in Pharmaceutical Sciences from the University of Missouri, Kansas City.
Kevin joined CAGE Bio in 2019 bringing 4+ years of formulation and transdermal research to the team. He has worked on various drug delivery technologies and holds transdermal drug delivery patents. Kevin received his B.S. in Chemistry from the University of California, Santa Barbara. Prior to joining CAGE, Kevin worked at Chrono Therapeutics.
Senior Research Associate
Chase joined the CAGE Bio team in 2022 bringing 8+ years of analytical chemistry and molecular biology research to the team. Prior to joining CAGE, he worked at UT Southwestern Medical Center researching sterol analytical chemistry in the Lipidomics Core Facility for Molecular Genetics. He received his M.S. from the University of North Texas in Biochemistry and Molecular Biology.
Patti has 25+ years of executive leadership experience with regulatory and quality oversight. Prior to joining CAGE Bio, Patti served as the Senior Vice President of Regulatory Affairs and Quality Assurance at Chrono Therapeutics. She has held positions at Incline Therapeutics (acquired by The Medicines Company), Onyx Pharmaceuticals (Amgen), Corgentech (Anesiva), Coulter (Corixa, GlaxoSmithKline), Genentech (Roche), and Syntex. Patti has worked on global regulatory submissions in several therapeutic areas.